Plain-English translation of NCT06957145 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand a protein called VISTA that may play a role in multiple sclerosis. This study will compare VISTA protein levels in blood samples from people recently diagnosed with MS or early MS symptoms to healthy people without MS, and track how these levels change over a year.
Multiple sclerosis happens when the immune system attacks the nervous system, but scientists don't fully understand all the factors that trigger this. By studying VISTA and how it works in MS patients, researchers hope to find new ways to diagnose, monitor, and treat this condition.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic three times over one year: at the start, at 6 months, and at 12 months. At each visit, researchers will take a blood sample and ask about your MS symptoms and any changes in how you're feeling. The blood samples will be analyzed in the lab to measure VISTA protein levels and how your immune cells respond to stimulation.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Turkey (Türkiye)